samedan logo
 
 
 
spacer
home > ebr > summer 2019 > the factory for next- generation therapies
PUBLICATIONS
European Biopharmaceutical Review

The Factory for Next- Generation Therapies

This edition of European Biopharmaceutical Review features articles that support the current momentum of discovery and development in a number of advanced cell and medicinal therapy areas. Unarguably, this is where medicine is headed. In terms of the latest advancements in cell-based therapies and cancer, we can now extract, reprogramme, expand, and reintroduce a patients’ own ‘supercharged’ T cells to fight B cell lymphoblastic leukaemia and B cell non-Hodgkin’s lymphoma through chimeric antigen receptor (CAR) T cell therapy. Could we have imagined this progress, or even the entire field of immunoncology, as it now stands 30 years ago?

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer

Print this page
Send to a friend
Privacy statement
News and Press Releases

LivaNova to Present Scientific Data on VNS Therapy for Difficult-to-Treat Depression at 4th International Brain Stimulation Conference

LivaNova PLC, a market-leading medical technology and innovation company, today announced its participation in the 4th International Brain Stimulation Conference, taking place December 6 - 9 in Charleston, S.C.
More info >>

White Papers

Preparation of Pharmaceutical Samples for Metals Analysis

RSSL

There has been a lot of discussion regarding the methods of analysis for pharmaceutical products as we await the upcoming changes to both the EP and USP, relating to the analysis of metal impurities.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement